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spontaneously hypertensive rats
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1 Isolated aortic rings (endothelium-intact and -denuded) from spontaneously hypertensive (SHR)
and Wistar-Kyoto (WKY) rats were used in this study to examine the vasoactive eects of various
adenosine analogues.
2 In phenylephrine contracted aortic rings, concentration-response curves were constructed by
cumulative additions (10711 – 1075 M) of (2S)-N6-[2-endo-Norbornyl] adenosine (ENBA), N6-
cyclopentyladenosine (CPA), R-N6-(2-phenylisopropyl) adenosine (R-PIA), 2-p-(-2-carboxyethyl)
phenethylamino-5’-N-thylcarboxamido adenosine (CGS-21680).
3 A non-specific adenosine receptor agonist 2-chloroadenosine (CAD) resulted in biphasic response
with a small contraction at lower concentrations (1079 – 1078 M) followed by a significant relaxation
at higher concentration in endothelium-intact SHR tissues, suggesting presence of both A1 and A2
adenosine receptors in SHR aorta. However, only relaxation was observed in WKY.
4 Contractile response in SHR had the following rank order of potency: ENBA4CPA4R-
PIA4CAD. The relaxation response in SHR and WKY had the following rank order of potency:
CGS 216804CAD4R-PIA4CPA4ENBA.
5 Removal of endothelium abolished the adenosine analogue induced contractions in SHR aorta
and attenuated the vasorelaxation responses in the WKY and SHR.
6 The contractile response in SHR was abolished by A1 adenosine receptor antagonist N
6-
endonorbornan-2-yl-9-methyladenine (N-0861). A2 adenosine receptor antagonist, 3,7-dimethyl-1-
proparglyxanthine (DMPX) did not aect the contraction response of adenosine analogues.
7 Endothelium-dependent contractions elicited by A1 receptor agonists were blocked by
indomethacin and by free radical scavengers.
8 These data suggest that the contractile response to adenosine analogues in SHR aorta is
probably mediated by free radicals which are generated through the increased cyclo-oxygenase
activity occurring in the vascular endothelium of SHR but not the WKY rats.
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L-NMMA, NG-monomethyl-L-arginine; N-0861, N6-endonorbornan-2-yl-9-methyladenine; NO, nitric oxide; PE,
phenylephrine; R-PIA, R-N6-(2-phenylisopropyl) adenosine; SHR, spontaneously hypertensive rats; U ml71,
units per ml; WKY, Wistar-Kyoto
Introduction
Adenosine is known for its protective role in myocardial
ischemia by reducing myocardial oxygen requirement and
increasing oxygen supply to the heart by vasodilation
(Belardinelli et al., 1989; Bruns, 1991). The eects of
adenosine are mediated through cell surface receptors
subdivided into A1 coupled to adenylate cyclase in an
inhibitory manner and A2 coupled to adenylate cyclase in a
stimulatory manner (Bruns et al., 1980). The vasodilatory
eects of adenosine and its analogues are mediated through
adenosine A2 receptors (Cushing et al., 1991; Laurent et al.,
1999; Lewis et al., 1994; Makujina et al., 1992; Mustafa &
Askar, 1985; Prentice & Hourani, 1996). Vasorelaxant
responses to adenosine are partly mediated through adeno-
sine induced release of endothelium derived relaxing factor
(EDRF) in some blood vessels (Fahim et al., 2001; Li &
Bukoski, 1993; Lockette et al., 1986; Luscher et al., 1990).
The negative inotropic and chronotropic actions of adenosine
have been shown to be mediated via the A1 adenosine
receptors (Ramagopal et al., 1993). Some of the reports have
indicated the presence of A1 adenosine receptors in blood
vessels of guinea-pig (Stoggall & Shaw, 1990) and dogfish
shark (Evans, 1992). In isolated vascular smooth muscle from
the ventral aorta of the dogfish shark A1 agonist ENBA
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produced significant increase in the tension only at higher
concentration (Evans, 1992).
Contractile adenosine A1 receptors have been demon-
strated in only a very few tissues, therefore the role of A1
adenosine receptor in the regulation of vascular tone remains
unresolved. There are several reports showing diminished
vasorelaxation response to adenosine in hypertension (Aze-
vedo & Osswald, 1992; Biaggioni, 1992; Fahim et al., 2001;
Illes et al., 1989), however there is no clear cut evidence of
exagerated contractile response to adenosine A1 receptor in
hypertension.
Therefore, in the present study we examined the eects of
specific A1 (Evans, 1992) and A2 (Makujina et al., 1992)
adenosine receptor agonists on the isolated aorta of
normotensive (WKY) and spontaneously hypertensive
(SHR) rats.
Methods
Spontaneously hypertensive (SHR) and Wistar Kyoto
(WKY) male rats of same age (15 – 17 weeks) were purchased
from Taconic (NY) and housed in plastic cages. Mean body
weights of these rats were 282+4 g (n=18) and 345+5 g
(n=20) for SHR and WKY, respectively. All animals were
fed standard chow and water ad libitum. Twelve hour light/
dark cycle was maintained. All experiments were approved by
the School of Medicine, East Carolina University Institu-
tional Animal Care and Use Committee and were carried out
under the guidelines for the Care and Use of Experimental
Animals. Each rat was weighed before use and blood pressure
was measured in the conscious state by using tail cu pump
(model 20-NW), pulse amplifier (model 59) and HR-pressure
meter (model 72) of IITC, Inc. Woodland Hills, CA, U.S.A.,
using a polygraph (model 7D, Grass Inst. Co., Quincy, MA,
U.S.A.). Mean systolic blood pressures were 175+4 and
124+2 mm Hg in SHR and WKY, respectively.
The rats were sacrificed by decapitation. Aortae were
dissected and cleaned of fat and connective tissue. Rings of
approximately 4 mm in length were prepared and vertically
mounted in 10 ml organ baths filled with Krebs –Henseleit
solution and oxygenated with 95% O2+5% CO2 (pH 7.4,
378C). The composition of Krebs –Henseleit buer was (mM):
NaCl, 118; KCl, 4.8; MgSO4, 1.2; KH2PO4 1.2; NaHCO3 25;
CaCl2, 2.5 and glucose, 11. Changes in isometric tension were
measured with force transducers (Grass FT .03) connected to
Sensormedics dynographs (R 611). Rings were equilibrated
for 1 h under an initial tension of 2 g (determined separately
from the length – tension relationship); the buer being
changed every 15 min. Rings were challenged with 1077 M
(ED *50) phenylephrine (PE) until constant and reproduci-
ble contractions were achieved. ED *50 values for
phenylephrine were calculated from phenylephrine concentra-
tion-response curves. The concentration of phenylephrine
producing approximately 50% of the maximum tension
developed in the aortic rings represents ED *50. After
achieving sustained and reproducible contractions with
1077 M PE, various agonists were added in a cumulative
fashion to the bath to obtain concentration-response curves.
In some of the aortic rings endothelium was denuded by
rotating a forcep inside the rings. The integrity of
endothelium was assessed by the ability of acetylcholine
(1076 M) to relax the PE-contracted vascular rings. In view
of the possible biphasic response of adenosine analogues, the
tissues were initially contracted with 1077 M phenylephrine
followed by concentration-response observations.
Concentration-response curves to ENBA, CAD, R-PIA, and
CGS-21680 were carried out in endothelium-intact and
-denuded rings from SHR and WKY aortae. Concentration-
response curves toENBA,CPAandR-PIAwere also carried out
following the treatment of endothelium-intact tissues with N-
0861, an adenosine A1 receptor antagonist (Barrett et al., 1992),
indomethacin (cyclo-oxygenase inhibitor), superoxide dismu-
tase plus catalase anddeferoxamine (free radical scavengers) and
dilazep (an adenosine uptake inhibitor). Concentration-
response curves to adenosine analogues were also carried out
in endothelium-intact rings from SHR and WKY before and
after treating the tissues withDMPX (1075 M), an adenosineA2
receptor antagonist (VanGalen et al., 1992).
Drugs
Phenylephrine, acetylcholine, indomethacin, superoxide dis-
mutase, catalase, defeorxamine and 2-chloroadenosine, were
obtained from Sigma. N6-cyclopentyladenosine (CPA), R-N6-
(2-phenylisopropyl)adenosine, (R-PIA), (2S)-N6-[2-endo-Nor-
bornyl]adenosine (S-ENBA), 2-p-(2-carboxyethyl)-phenethy-
lamine-5’-N-ethylcarboxamidoadenosine (CGS-21680), N6-
endonorbornan-2-yl-9-methyladenine (N-0861), and 3,7-di-
methyl-1-propargylxanthine (DMPX), NG monomethyl-L-
arginine (L-NMMA) were purchased from Research Bio-
chemicals, Inc. (MA). Dilazep was a gift from Asta Medica
(Frankfurt, Germany) and N-0861 was a gift from Discovery
Therapeutics Inc. (Richmond, VA, U.S.A.).
Statistical analysis
The responses to adenosine analogues were expressed as per
cent contraction over that obtained with 1077 M PE. All
values are expressed as mean+s.e.mean. Statistical signifi-
cance was determined using two-way analysis of variance
(ANOVA). Dierences from the control (tension produced by
1077 M phenylephrine) were calculated using a paired, 2-
tailed, Student’s t-test. The P value for statistical significance
was set at 0.05 level.
Results
Concentration-response curves to adenosine receptor
agonists
Phenylephrine (1077 M) produced 750+66 mg tension in
endothelium intact aortic rings of WKY, 895+87 mg in
SHR, 790+71 mg and 882+79 mg in endothelium-denuded
aortic rings of WKY and SHR respectively. The contractile
responses to 1077 M phenylephrine were not statistically
dierent (P40.05) between WKY and SHR. ENBA (10710 –
1076 M) produced significant (P50.05) contractile response in
endothelium-intact aortic rings from SHR (Figure 1A). It
produced maximum contractile eect at a concentration of
1078 M in SHR rings. Higher concentrations of ENBA caused
reduction in contractile response in SHR and at 1075 M
concentration, contractile eect of ENBA had disappeared
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(Figure 1A). Endothelium-denuded rings from SHR and
endothelium-intact or -denuded rings fromWKY did not show
any significant (P40.05) contractile response to ENBA (Figure
1A).
Endothelium-intact rings from SHR showed contractile
response to R-PIA and CPA at concentrations ranging from
10710 – 1076 M which were diminished at 1075 M (Figure
1B,C). Endothelium-denuded rings from SHR did not show
any significant contractile response to R-PIA or CPA (Figure
1B,C). R-PIA or CPA did not produce any contractile eect
in WKY tissues with or without endothelium (Figure 1B,C).
At higher concentrations (106 – 1075 M) of R-PIA or CPA, a
vasorelaxant eect was observed which was attenuated in
endothelium-denuded rings from WKY (Figure 1B,C).
CAD and CGS-21680 at concentrations ranging from
1079 – 1078 M showed a small contractile response in
endothelium-intact SHR tissues which was not found to be
statistically significant (P40.05) (Figure 1D,E). CAD and
CGS-21680 did not produce any contraction in WKY tissues
(Figure 1D,E). CAD (107 – 1075 M) and CGS-21680 (1078 –
1075 M) produced significant relaxations in endothelium-
intact aortic rings which were attenuated in the absence of
endothelium in rings from SHR (Figure 1E).
Effect of N-0861 on the responses to adenosine analogues
N-0861 (1075 M), a relatively A1 selective antagonist (Barrett et
al., 1992) did not produce any significant (P40.05) eect on the
contractile response to phenylephrine (1077 M) in WKY and
SHR tissues and abolished the contractions elicited by ENBA
(Figure 2A), R-PIA and CPA. R-PIA produced a concentra-
tion-dependent relaxant response in endothelium-intact aortic
rings from SHR (Figure 3A,C). However, the relaxation
response in WKY was not aected by N-0861.
Effect of dilazep and indomethacin on responses to ENBA
Treatment of aortic rings from WKY and SHR with
dilazep (1075 M) caused a significant fall in the contractile
response to phenylephrine (1077 M) (Table 1). The con-
tractile response to higher concentrations of ENBA in SHR
was more in the rings treated with dilazep than the control
Figure 1 Concentration-response curves for adenosine analogues ENBA (A), R-PIA (B), CPA (C), CAD (D) and CGS 21680 (E)
in endothelium-intact and -denuded aortic rings from WKY and SHR. *Significantly dierent from the control (C on X-axis);
P50.05. The points represent the mean and the vertical lines the s.e.mean.
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(Figure 2B). Indomethacin produced a significant fall in the
contractile response to phenylephrine (1077 M) only in SHR
and not in WKY (Table 1). In the presence of
Indomethacin (1075 M) ENBA produced significant relaxa-
tions in endothelium-intact aortic rings from WKY and
SHR (Figure 2C).
Effect of free radical scavengers on the responses to
adenosine analogues
Incubation of tissues with free radical scavengers produced a
significant fall in contractile response to phenylephrine
(1077 M) in SHR (Table 1). Pretreatment of endothelium-
Figure 2 Eect of N-0861 (A), dilazep (B), indomethacin (C) and free radical scavenger (superoxide dismutase+catalase+defer-
oxamine) (D) treatment on the concentration-response curve for ENBA in WKY and SHR before and after the treatment.
*Significantly dierent from the control (C on X-axis); P50.05. The points represent the mean and vertical lines the s.e.mean.
Figure 3 Eect of N-0861 (A, C) and free radical scavengers (superoxide dismutase+catalase+deferoxamine) treatment on the
concentration-response curves for R-PIA (B) and CPA (D) in WKY and SHR before and after the treatment. *Significantly
dierent from the control (C on X-axis); P50.05. The points represent the mean and vertical lines the s.e.mean.
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intact tissues with superoxide dismutase (150 U ml71),
catalase (600 U ml71) and deferoxamine (1074 M) abolished
the contractile response to ENBA in SHR (Figure 2D) and
produced an increased relaxation in both SHR and WKY
tissues. Similar responses were observed with R-PIA and
CPA in both SHR and WKY tissues treated with free radical
scavengers (Figure 3B,D).
Effect of DMPX on the responses to adenosine analogues
Treatment of tissues with A2 adenosine receptor antagonist
DMPX produced larger contractile response to 1077 M
phenylephrine in both WKY and SHR (Table 1). Concentra-
tion-response curves to adenosine analogues were carried out in
the absence and presence of A2 adenosine receptor antagonist
DMPX (1075 M) (VanGalen et al., 1992). Blocking of A2
adenosine receptors, which are known to be involved in
vasorelaxation elicited by adenosine, did not alter the
contractile response of adenosine analogues R-PIA and CPA
in SHR tissues while blocking the relaxation response (data not
shown). Also, the inhibition of NO production with NG-
monomethyl-L-arginine (L-NMMA) did not abolish the
contractile response in SHR tissues to adenosine analogues
R-PIA and CPA (data not shown).
Discussion
Our results clearly demonstrate a contractile response to
several adenosine analogues (ENBA, CPA and R-PIA) in
endothelium-intact aortic rings from SHR but not in WKY.
These contractions are known to be directed by activation of
A1 adenosine receptors (Linden, 1991). The contractions by
these adenosine analogues in SHR tissues were blocked by N-
0861, an antagonist for A1 adenosine receptor. DMPX, an A2
adenosine receptor antagonist (VanGalen et al., 1992) did not
aect the contractile response to the adenosine analogues
with a preference to A1 receptor in SHR suggesting that the
nature of A2 antagonism by DMPX was competitive.
Previous studies have shown that the vasorelaxation
response to adenosine and its analogues is attenuated in
certain pathological conditions aecting the blood vessels,
e.g., hypertension (Fahim et al., 1993; Li & Bukoski, 1993;
Lockette et al., 1986; Luscher et al., 1987) and diabetes
(Tesfamariam & Cohen, 1992). Furthermore, the use of a
more specific A1 adenosine receptor agonist ENBA, which
has an A1/A2 potency ratio of 4700 in rat brain membranes
(Trivedi et al., 1989) produced a significant contraction
response in comparison to other A1 adenosine analogues (R-
PIA and CPA) (Linden, 1991). Vascular smooth muscle from
WKY did not show contractile response to any A1 adenosine
receptor agonist, therefore, it is unlikely that under normal
conditions there is counteraction of A1 receptor mediated
contractions by A2 receptor-mediated relaxations as firstly,
A1-selective agonists did not evoke contractions in WKY,
and secondly, antagonism of A2 receptors did not reveal
contractions. However, in our study, neither DMPX, an A2
receptor antagonist (VanGalen et al., 1992) nor inhibition of
NO synthesis by L-NMMA could influence the contractile
response to adenosine analogues in SHR aorta. Removal of
the endothelium abolished the contractile response to ENBA,
R-PIA and CPA, while response to CGS-21680, and CAD
was significantly reduced. CGS-21680 produced the max-
imum relaxation in WKY in comparison to other analogues,
suggesting its high specificity for A2 receptor mediation. In
vascular tissues from WKY rats, CAD and CGS-21680 did
not produce any contraction and caused stronger relaxations
as compared to SHR. The dierence in the vasorelaxant
responses to CAD and CGS-21680 between SHR and WKY
vascular tissues were reduced in endothelium-denuded rings,
suggesting that the attenuation in vasorelaxation to CAD and
CGS-21680 in SHR tissues is due to endothelium malfunc-
tion. The biphasic response to several adenosine analogues in
endothelium-intact tissues of SHR suggests the presence of
both constrictor (A1) and dilator (A2) adenosine receptors.
The presence of A1 and A2 adenosine receptors has been
reported in guinea-pig aorta (Stoggall & Shaw, 1990) and
ventral aorta of the dogfish shark (Evans, 1992). Since
DMPX or L-NMMA did not produce any significant eect
on contractile response of ENBA, R-PIA, and CPA,
therefore, it is unlikely that inhibition of A2 receptor
mediated relaxation or release of EDRF would have any
role in the adenosine A1 receptor induced vasoconstrictor
response in SHR. The chronic exposure of rats to A1
adenosine receptor agonist R-PIA decreases A1 receptor
number along with an increase in basal and agonist
stimulated adenylate cyclase activity in adipocytes and it is
suggested that the regulation of both G2 and G1 proteins had
a major role in the desensitization process of A1 receptor-
adenylate cyclase system (Parsons & Stiles, 1987). Therefore,
the lack of contraction in aortae from SHR at higher
concentrations of the agonists during cumulative concentra-
tion-response desensitization of the A1 receptor.
The other possible mechanism(s) involved in contractile
response to adenosine analogues in SHR could be the release
of EDCF and/or cyclo-oxygenase products from the vascular
endothelium. Inhibition of endothelium-dependent vasore-
laxation to agonists in blood vessels of hypertensive (Li &
Table 1 Influence of indomethacin (10 mM), dilazap (10 mM), free radical scavenger (superoxide dismutase 150 U ml71, catalase
600 U ml71 and defroxamine 1074 M and DMPX on contractile response (mg) to 1077 M phenylephrine in WKY and SHR.
WKY SHR
Treatment n Cont. Treated n Cont. Treated
Indomethacin 5 810+72 824+91 5 935+82 812+70*
Dilazap 5 827+59 732+66* 5 902+101 792+111*
Free radical scavenger 5 790+85 752+75* 5 907+92 810+88*
DMPX 3 875+79 952+102 5 914+101 972+98
The data are expressed as mean+s.e.mean, n=number of animals in each group, from each animal five tissues were taken. A paired
test was used to test the dierences in response to phenylephrine between control and after treatment. *Significantly dierent from the
control; P50.05.
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Bukoski, 1993; Luscher et al., 1990) and diabetic (Tesfamar-
iam & Cohen, 1992) animals has been suggested to be due to
vasoconstrictor cyclo-oxygenase products. The release of a
cyclo-oxygenase dependent EDCF (Auch-Schwelk & Van-
houtte, 1992; Taddei & Vanhoutte, 1993) in SHR vessels also
indicated the involvement of cyclo-oxygenase products in the
vasoconstriction response. In our study, contractile response
of adenosine analogues in SHR aorta was blocked by
indomethacin suggesting that the contractions elicited by
adenosine analogues in SHR could partly be mediated
through the release of certain cyclo-oxygenase products
(EDCF) from the endothelial cells of SHR aorta. Earlier
studies have indicated the release of a cyclo-oxygenase
dependent EDCF in SHR blood vessels (Auch-Schwelk &
Vanhoutte, 1992; Taddei & Vanhoutte, 1993). Cyclo-
oxygenase mediated contractile response to A1 adenosine
receptor stimulation has been reported in other tissues also.
In cat lung and guinea-pig uterus and trachea, responses
mediated by A1 receptors are markedly attenuated by
inhibitor of cyclo-oxygenase (Caparrotta et al., 1984; Neely
et al., 1991; Schiemann et al., 1991). These workers suggested
that smooth muscle contraction in these tissues may be
secondary to the synthesis of prostaglandin from arachidonic
acid indicating the involvement of cyclo-oxygenase products
in the contractile response to A1 receptor stimulation.
Oxygen-derived free radicals are known to inhibit
endothelium-dependent vasorelaxation (Todoki et al., 1992;
Tesfamariam & Cohen, 1992) and cause endothelium-
dependent contraction (Katusic et al., 1993) through cyclo-
oxygenase pathway. In this study, free radical scavengers
(superoxide dismutase+catalase+deferoxamine) blocked the
contractile response to A1 adenosine receptor agonists in
SHR aorta indicating a role of oxygen-derived free radical
generation from the endothelium.
Indomethacin or free radical scavenger per se caused
significant relaxation of the aortic rings from WKY and
SHR. Abolition of contractile response of ENBA following
indomethacin or free radical scavenger treatment could not
be due to the fall in tension of PE contracted aortic rings
because a similar fall in tension by dilazep, an adenosine
uptake inhibitor, did not block ENBA induced contractile
response of SHR aorta. Treatment of tissues with a higher
concentration of PE (561077 M) producing same magnitude
of contraction as before incubation of tissue with indometha-
cin or free radical scavengers did not produce any contractile
response to ENBA. Dilazep treated tissues showed a small
increase in the contraction of SHR tissues by ENBA
probably due to the fall in tension by dilazep.
In conclusion, these data indicate that in SHR aorta, the
endothelium-dependent contractile response to adenosine
analogues appeared to be A1 adenosine receptor mediated
and the relaxant response in WKY and SHR aortae appeared
to be through A2 adenosine receptors. The contractions
evoked by A1 adenosine receptor agonists in SHR aorta are
likely to be mediated by free radicals possibly generated
through the increased release of cyclo-oxygenase products
from the endothelium of SHR aorta.
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